K
KeyMed Biosciences Inc
HKEX:2162
KeyMed Biosciences Inc
HKEX:2162
Price:
59.5
HKD
-1.65%
Market Closed
Market Cap:
HK$17.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
Tsuruha Holdings Inc
TSE:3391
|
JP |
|
Newlat Food SpA
MIL:NWL
|
IT |
|
Insperity Inc
NYSE:NSP
|
US |
|
Bayan Resources Tbk PT
IDX:BYAN
|
ID |
|
Leggett & Platt Inc
NYSE:LEG
|
US |
|
B
|
Bank CIMB Niaga Tbk PT
IDX:BNGA
|
ID |
|
Selective Insurance Group Inc
NASDAQ:SIGI
|
US |
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
Shanghai Jinjiang Shipping Group Co Ltd
SSE:601083
|
CN |
|
China Resources Beer Holdings Co Ltd
HKEX:291
|
HK |
|
L
|
Life Science REIT PLC
LSE:LABS
|
UK |
|
Elm Company SJSC
SAU:7203
|
SA |
|
Hanover Insurance Group Inc
NYSE:THG
|
US |
|
Cohu Inc
NASDAQ:COHU
|
US |
|
CLARIVATE PLC
NYSE:CLVT
|
UK |
|
Baozun Inc
NASDAQ:BZUN
|
CN |
|
Duke Energy Corp
NYSE:DUK
|
US |
|
Fabrinet
NYSE:FN
|
KY |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
CK Asset Holdings Ltd
HKEX:1113
|
HK |
|
Anheuser Busch Inbev SA
XETRA:1NBA
|
BE |
Wall St Price Targets
Price Targets Summary
KeyMed Biosciences Inc
KeyMed Biosciences Inc
Wall Street analysts forecast KeyMed Biosciences Inc stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 89.42 HKD with a low forecast of 77.77 HKD and a high forecast of 107.73 HKD.
Lowest Forecast
Price Target
77.77
HKD
31% Upside
Average Forecast
Price Target
89.42
HKD
50% Upside
Highest Forecast
Price Target
107.73
HKD
81% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KeyMed Biosciences Inc's stock price target?
Price Target
89.42
HKD
89.42
HKD
According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 89.42 HKD with a low forecast of 77.77 HKD and a high forecast of 107.73 HKD.
What is the Revenue forecast for KeyMed Biosciences Inc?
Projected CAGR
31%
31%
The compound annual growth rate for Revenue over the next 7 years is 31%.
